3 doses of mRNA COVID vaccine show advantage against severe outcomes
Mary Van Beusekom, MS October 15, 2024 University of Minnesota A team led by US Food and Drug Administration (FDA) researchers studying Medicare claims data during the early Omicron SARS-CoV-2 variant months conclude that a third dose of mRNA COVID-19 vaccine provides significant protection against hospitalization and death compared with two doses but wanes substantially […]